Haemonetics (HAE) Q3 Earnings Meet Estimates [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
In This Article HAE Haemonetics (HAE) came out with quarterly earnings of $1.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.04 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this provider blood management systems for health care providers and blood collectors would post earnings of $1.09 per share when it actually produced earnings of $1.12, delivering a surprise of 2.75%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Haemonetics , which belongs to the Zacks Medical - Products industry, posted revenues of $348.54 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 1.30%. This compares to year-ago revenues of $336.25 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recentl
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.MarketBeat
- Riverwater Partners Small Cap Strategy Sold Its Stake in Haemonetics Corporation (HAE) in Q3 [Yahoo! Finance]Yahoo! Finance
- Haemonetics (NYSE:HAE) was upgraded by analysts at CJS Securities to a "strong-buy" rating.MarketBeat
- Haemonetics (NYSE:HAE) was given a new $99.00 price target on by analysts at Robert W. Baird.MarketBeat
- Haemonetics (NYSE:HAE) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.MarketBeat
HAE
Earnings
- 11/7/25 - Beat
HAE
Sec Filings
- 11/12/25 - Form 4
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- HAE's page on the SEC website